<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1096</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2008-4-2-22-25</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак почки</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Ki-67 nuclear antigen as a prognostic factor in renal cell carcinoma</article-title><trans-title-group xml:lang="ru"><trans-title>Ядерный антиген Ki-67 как фактор прогноза при почечно-клеточном раке</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varlamov</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Варламов</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Barnaul</p></bio><bio xml:lang="ru"><p>Барнаул</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Doroshenko</surname><given-names>V. S.</given-names></name><name xml:lang="ru"><surname>Дорошенко</surname><given-names>В. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Barnaul</p></bio><bio xml:lang="ru"><p>Барнаул</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazarev</surname><given-names>A. F.</given-names></name><name xml:lang="ru"><surname>Лазарев</surname><given-names>А. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Barnaul</p></bio><bio xml:lang="ru"><p>Барнаул</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Altai branch of Public institution Russian Oncologic Research Center named after N.N. Blohin, Altai regional oncologic clinic</institution></aff><aff><institution xml:lang="ru">Алтайский филиал ГУ РОНЦ им. Н.Н. Блохина РАМН, ГУЗ Алтайский краевой онкологический диспансер</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2008-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2008</year></pub-date><volume>4</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>22</fpage><lpage>25</lpage><history><date date-type="received" iso-8601-date="2020-02-15"><day>15</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-02-15"><day>15</day><month>02</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1096">https://oncourology.abvpress.ru/oncur/article/view/1096</self-uri><abstract xml:lang="en"><p>Great attention paid to renal cell carcinoma (RCC) is due to increase in its prevalence. This paper is devoted to comparison of classic clinical and pathological prognostic factors and expression character of proliferation marker Ki-67 in this cancer. Proliferative activity was analyzed in 101 cases of RCC by immunohistochemical assays using antibodies to the Ki-67. High index Ki-67 was diagnosed more often in an aggressive variants RCC and Fuhrman grade 3–4 tumors. Besides, RCC with high proliferative activity had significantly lower time of appearance of distant metastases and poor survival in coparison with RCC with low proliferative activity.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Давыдов М.И., Аксель Е.М. Злокачественные новообразования в России и странах СНГ в 2002 г. М., Медицинское информационное агентство; 2004. с. 279.</mixed-citation><mixed-citation xml:lang="ru">Давыдов М.И., Аксель Е.М. Злокачественные новообразования в России и странах СНГ в 2002 г. М., Медицинское информационное агентство; 2004. с. 279.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Матвеев В.Б., Волкова М.И. Рак почки. М., Федеральная целевая программа «Предупреждение и борьба заболеваний социального характера»; 2005. с. 255-62.</mixed-citation><mixed-citation xml:lang="ru">Матвеев В.Б., Волкова М.И. Рак почки. М., Федеральная целевая программа «Предупреждение и борьба заболеваний социального характера»; 2005. с. 255-62.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Романенко А.М., Бош-Ломбарт Л. Иммуногистохимическая диагностика опухолей почек. Под ред. С.В. Петрова, Н.Т. Райхлина. Руководство по иммуногистохимической диагностике опухолей. 2-е изд. Казань, «Титул»; 2004. с. 93–100.</mixed-citation><mixed-citation xml:lang="ru">Романенко А.М., Бош-Ломбарт Л. Иммуногистохимическая диагностика опухолей почек. Под ред. С.В. Петрова, Н.Т. Райхлина. Руководство по иммуногистохимической диагностике опухолей. 2-е изд. Казань, «Титул»; 2004. с. 93–100.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Delahunt B. Histopatologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 1998;15:68–76.</mixed-citation><mixed-citation xml:lang="ru">Delahunt B. Histopatologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 1998;15:68–76.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Fuhrman S.A., Lasky L.S., Limas C. Prognostic significance of morfologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;(6):655–63.</mixed-citation><mixed-citation xml:lang="ru">Fuhrman S.A., Lasky L.S., Limas C. Prognostic significance of morfologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;(6):655–63.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Usubutum A., Ayhan A., Uygur M.C. et al. Prognostic factors in renal cell carcinoma. J Exp Clin Cancer Res 1998;17:77–81.</mixed-citation><mixed-citation xml:lang="ru">Usubutum A., Ayhan A., Uygur M.C. et al. Prognostic factors in renal cell carcinoma. J Exp Clin Cancer Res 1998;17:77–81.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Bui M.H., Visapaa H., Seligson D. et al. Prognostic value of carbonic anhydrase IX and Ki-67 as predictors of survival for renal cell carcinoma. J Urol 2004;171(6):2461-6.</mixed-citation><mixed-citation xml:lang="ru">Bui M.H., Visapaa H., Seligson D. et al. Prognostic value of carbonic anhydrase IX and Ki-67 as predictors of survival for renal cell carcinoma. J Urol 2004;171(6):2461-6.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Rioux-Leclercq N., Turlin B., Bansard J. et al. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology 2000;55:501–5.</mixed-citation><mixed-citation xml:lang="ru">Rioux-Leclercq N., Turlin B., Bansard J. et al. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology 2000;55:501–5.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;152(3):311–22.</mixed-citation><mixed-citation xml:lang="ru">Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;152(3):311–22.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Slaton J.W., Inoue K., Perrotte P. et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renall cell carcinoma. Am J Path 2001;158(2):735–43.</mixed-citation><mixed-citation xml:lang="ru">Slaton J.W., Inoue K., Perrotte P. et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renall cell carcinoma. Am J Path 2001;158(2):735–43.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
